Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Assets (2018 - 2025)

Historic Return on Assets for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to 0.28%.

  • Dianthus Therapeutics' Return on Assets fell 900.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.31% for FY2024, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, Dianthus Therapeutics' Return on Assets is 0.28%, which was down 900.0% from 0.34% recorded in Q2 2025.
  • Dianthus Therapeutics' Return on Assets' 5-year high stood at 0.14% during Q4 2022, with a 5-year trough of 0.44% in Q2 2023.
  • Its 4-year average for Return on Assets is 0.25%, with a median of 0.23% in 2023.
  • As far as peak fluctuations go, Dianthus Therapeutics' Return on Assets tumbled by -2500bps in 2023, and later soared by 2900bps in 2024.
  • Over the past 4 years, Dianthus Therapeutics' Return on Assets (Quarter) stood at 0.14% in 2022, then plummeted by -61bps to 0.23% in 2023, then rose by 1bps to 0.23% in 2024, then dropped by -20bps to 0.28% in 2025.
  • Its Return on Assets stands at 0.28% for Q3 2025, versus 0.34% for Q2 2025 and 0.28% for Q1 2025.